ArticleeLife2026

Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment.

Youyou Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.